“5-AMINO-1MQ 10mg” has been added to your cart. View cart
BPC-157
$75.00–$90.00Price range: $75.00 through $90.00
Each unit corresponds to one research vial. For laboratory use only.
SHIPPING INFORMATION
All Orders Ship from Canadian Warehouse
Re-tested & Quality-Verified
ℹ️ What does Canadian Warehouse shipping mean?
Warehouse ShippingAll orders are shipped from our Canadian warehouse. Products are re-tested and quality-verified in Canadian laboratories prior to domestic shipment. This includes expedited Canadian re-test handling, ensuring additional quality verification steps are completed in domestic facilities. Products undergo additional quality control testing in Canada before shipment, with faster domestic delivery times. An expedited handling fee applies to all orders.
Description
BPC-157 research peptide: quick research overview
Studies involving BPC-157 research peptide have examined the areas below. Results vary by model, and the limits matter when interpreting them.
What researchers have studied
Tissue-repair, gastrointestinal and vascular processes in cell and animal models
Cell movement, inflammatory signalling and oxidative-stress pathways
How results change with the model, material identity and formulation
What the research does not prove
Published findings apply only to the material, formulation, model and protocol that were tested
Laboratory or clinical findings do not prove that this catalogue product is safe or effective for personal use
This research product is not equivalent to a Health Canada-authorized medicine or finished clinical product
Laboratory research only—not for human or veterinary use
Bottom line: these points describe research areas and evidence limits, not product benefits or treatment advice.
BPC-157 research peptide Canada product information: this BPC-157 is supplied as a lyophilized research material in 10 mg and 20 mg vial formats for qualified laboratory and analytical work only. It is not a medicine, supplement or cosmetic, and it is not intended for human or veterinary use.
Research-use notice: BPC-157 is an investigational compound. This product has not been approved by Health Canada or the U.S. FDA for diagnosing, treating, curing or preventing any disease. No dosing, administration or reconstitution guidance is provided.
BPC-157 research peptide supplied for controlled laboratory research only—not for human or veterinary use.
Researchers should verify the identity, form, concentration and current batch documentation before designing any protocol. The identifiers above describe BPC-157 as listed for this product; they do not establish therapeutic approval or suitability for a particular experiment.
What is BPC-157 research peptide?
BPC-157 is a synthetic 15-amino-acid peptide commonly described in the scientific literature as a partial sequence associated with a gastric peptide known as body protection compound. Its sequence—GEPPPGKPADDAGLV—has been studied primarily in cell-based and animal models. Search interest often centres on tissue, gastrointestinal, vascular and inflammatory pathways, but those research themes should not be interpreted as proven benefits in people.
A 2026 PubMed-indexed review of BPC-157 development barriers concluded that the compound remains pharmaceutically underdeveloped. The review identified major gaps in validated formulations, human pharmacokinetics and controlled clinical research. Another review of musculoskeletal research described extensive preclinical interest but extremely limited human evidence.
That evidence boundary matters. BPC-157 laboratory research can explore biochemical questions, analytical methods and experimental models. It cannot support a claim that this research material is a safe or effective treatment.
BPC-157 Canada regulatory context
This product is sold strictly for research use only. A research label is not a Health Canada drug authorization, and it does not permit personal use. Health Canada advises Canadians to use the official Drug Product Database to verify whether a drug is authorized for sale and to review its product monograph.
The U.S. regulatory discussion is separate from Canadian law. In July 2026, the FDA Pharmacy Compounding Advisory Committee reviewed BPC-157-related bulk drug substances for possible inclusion on the American 503A Bulks List. The official FDA meeting materials explain that advisory recommendations are non-binding and are not the same as approval of a finished drug.
The FDA has also identified possible immunogenicity, peptide-impurity and active-ingredient-characterization concerns for compounded BPC-157, while noting that it lacks enough safety information for proposed human routes. Researchers can review the agency’s current bulk-substance safety summary directly.
BPC-157 research peptide applications and evidence limits
Published BPC-157 research has examined several experimental areas. Most findings come from preclinical models, and results can vary with the model, material identity, formulation and analytical method.
Stability research: behaviour under defined temperature, solvent, light and time conditions.
Cellular models: exploratory work involving signalling, migration, oxidative stress and inflammatory pathways.
Preclinical tissue models: experimental investigation of gastrointestinal, tendon, muscle, nerve and vascular processes.
Method development: validated analytical workflows for detecting BPC-157 and related impurities.
These are research categories, not product claims. Laboratory findings and animal data do not establish clinical safety, dosage, effectiveness or legal therapeutic use. No statement on this page should be interpreted as medical advice.
Quality checks for BPC-157 research peptide
A useful BPC-157 research peptide is not defined by a purity percentage alone. Laboratories should evaluate the complete analytical picture and match it to the needs of their protocol.
Identity and sequence confirmation
Mass spectrometry can help confirm molecular identity, while sequence-specific methods may be needed when the research question requires a higher level of structural certainty. The reported molecular mass should be interpreted alongside the peptide form, counter-ion and hydration state.
Chromatographic purity
High-performance liquid chromatography can estimate the relative abundance of the main component and detectable impurities under a defined method. A chromatogram should be reviewed with the method, wavelength, integration approach and acceptance criteria—not as an isolated headline number.
Batch documentation
Researchers should review the current certificate of analysis and any available supporting documentation for the exact lot received. The product name, batch identifier, test date and analytical results should correspond across the label and records. Our Canadian research-peptide sourcing guide explains how to evaluate COAs, supplier transparency and laboratory documentation.
Contamination and suitability
Purity does not automatically establish sterility, endotoxin status, residual-solvent limits or suitability for biological work. Each laboratory remains responsible for its own risk assessment, safety controls and method validation.
10 mg and 20 mg BPC-157 research formats
This BPC-157 research peptide is listed in 10 mg and 20 mg vial formats. The format selection is a procurement decision for the laboratory and should match the approved protocol, analytical sensitivity, replication plan, instrument workflow and material-control procedures.
10 mg format: suitable when a protocol calls for a smaller total quantity or when separate units are useful for batch control.
20 mg format: suitable when an authorized project requires more material from a single listed format.
The vial amount is not a human dose and should never be interpreted as administration guidance. This page intentionally provides no reconstitution, injection or consumption instructions.
Laboratory handling and documentation
Only trained personnel should handle BPC-157 research material. Follow the product label, current safety documentation, institutional chemical-hygiene plan and approved protocol. Record the lot number, receipt date, storage history and chain of custody. Use calibrated equipment and controls appropriate to the analytical method.
Because stability depends on the material form and experimental conditions, researchers should rely on the current product documentation rather than informal consumer guidance. Do not use a vial if the seal, label or batch information is missing or inconsistent. Contact the supplier before proceeding when documentation cannot be reconciled.
BPC-157 is prohibited under the World Anti-Doping Agency’s S0 Non-Approved Substances category. The U.S. Anti-Doping Agency’s BPC-157 guidance states that human efficacy has not been established and warns athletes about the compound’s prohibited status. Athletes should consult the current WADA Prohibited List and Global DRO for up-to-date rules.
Frequently asked questions about BPC-157 research peptide Canada
What is this BPC-157 research peptide product?
It is a synthetic pentadecapeptide research material supplied in lyophilized form for qualified laboratory and analytical work only.
What BPC-157 research peptide vial formats are available?
The product is listed in 10 mg and 20 mg formats. Those amounts describe the material in the vial and are not human doses.
What is the BPC-157 amino-acid sequence?
The listed sequence is GEPPPGKPADDAGLV, a chain of 15 amino acids.
What is the CAS number for BPC-157?
The listed CAS Registry Number is 137525-51-0. Researchers should confirm that identifier against the product label and current batch documentation.
What is the PubChem identifier?
The listed PubChem Compound ID is 9941957.
Is BPC-157 research peptide approved by Health Canada?
This product is not approved by Health Canada for any therapeutic purpose. Search Health Canada’s Drug Product Database for current Canadian drug authorizations.
Is BPC-157 approved by the FDA?
BPC-157 is not an FDA-approved finished drug. A U.S. advisory discussion about pharmacy-compounding rules is not conventional drug approval.
Can this BPC-157 product be used by people or animals?
No. It is sold for laboratory research only and is not intended for human or veterinary use.
Does research use only permit self-experimentation?
No. Research use only identifies a controlled laboratory context; it is not a pathway for personal consumption, treatment or performance enhancement.
Does BPC-157 have proven medical benefits?
No medical benefit is established for this product. BPC-157 evidence is dominated by preclinical work, while controlled human evidence remains very limited.
How should a laboratory assess BPC-157 research peptide quality?
Review identity, chromatographic purity, mass confirmation, batch traceability and any additional tests relevant to the protocol. A purity percentage alone is not enough.
Does a COA prove that a product is safe for people?
No. A certificate of analysis documents specified laboratory tests for a batch. It does not provide Health Canada approval, clinical evidence or permission for human use.
Is BPC-157 prohibited in sport?
Yes. WADA classifies BPC-157 under S0 Non-Approved Substances. Competitive athletes should check current official anti-doping resources.
Does this page provide dosing or reconstitution instructions?
No. The product is not for human or veterinary use, so no dosing, administration or self-experimentation instructions are provided.
Where can I learn more about BPC-157 evidence?
Start with our BPC-157 Canada research guide, then review the linked FDA, Health Canada, PubMed and anti-doping sources directly.
Important research-use disclaimer
BPC-157 is supplied solely for qualified laboratory and analytical research. It is not for human or veterinary use, food use, cosmetic use, compounding, diagnosis or treatment. It has not been approved by Health Canada or the FDA for any therapeutic purpose. Purchasers are responsible for legal compliance, institutional authorization, safe handling, documentation and appropriate disposal.
Regulatory Notice: This product has not been evaluated by the Food and Drug Administration (FDA). It is not approved for human or veterinary use, diagnosis, treatment, cure, or prevention of any disease.
Important Research Note: The information provided on this website is for research and educational purposes only. This information does not constitute medical advice, diagnosis, or treatment. Consult with qualified healthcare professionals for medical guidance.
Safety & Handling Disclaimer: Products are sold “as is” without warranty. The buyer assumes all risk and liability for the results obtained by the use of any product. Use at your own risk.
CHEMICAL FORMULA:
C62H98N16O22
MOLAR MASS:
1419.5 g/mol
CAS NUMBER:
137525-51-0
PUBCHEM ID:
9941957
Important Research Note: The information provided on this website is for research and educational purposes only. This information does not constitute medical advice, diagnosis, or treatment. Consult with qualified healthcare professionals for medical guidance.
Safety & Handling Disclaimer: Products are sold “as is” without warranty. The buyer assumes all risk and liability for the results obtained by the use of any product. Use at your own risk.
You must be 18 or 19 years of age depending on the age of majority in your province and a licensed research professional
All products are sold in powder (lyophilized) form and require reconstitution with a suitable diluent for research purposes only. No dosing instructions are provided. We adhere to all provincial and federal laws in Canada around Research Only Chemical sales. We are not a pharmacy and/or compounding facility, nor do we promote or provide any advice for human or animal consumption.
By clicking ”I Agree” you confirm that you have read and accepted the Terms and Conditions stated above.
